Clinical Trial Update: A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated GDC-0941 (pictilisib) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole, in locally r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• GDC-0941 (pictilisib) (GDC-0941)
• Letrozole (letrozole)
• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED